Sense prevails on MRI rules

Scientists in Europe have been expressing linkurl:relief;http://www.guardian.co.uk/science/2007/oct/22/medicalresearch.health this week at the news that the European Union is dropping rules on the levels of radiation medical staff can be exposed to. The EU physical agents directive had triggered linkurl:consternation;https://www.the-scientist.com/article/display/22775/ a couple of years ago, with researchersworried it would be impossible to do certain kinds of studies and keep within the prescri

By | October 22, 2007

Scientists in Europe have been expressing linkurl:relief;http://www.guardian.co.uk/science/2007/oct/22/medicalresearch.health this week at the news that the European Union is dropping rules on the levels of radiation medical staff can be exposed to. The EU physical agents directive had triggered linkurl:consternation;https://www.the-scientist.com/article/display/22775/ a couple of years ago, with researchersworried it would be impossible to do certain kinds of studies and keep within the prescribed limits. The linkurl:rules;http://www.hpa.org.uk/radiation/understand/information_sheets/mri_ec_directive_2004_40_ec.htm were due to come into force by next year. But now, after some serious lobbying coordinated by the group Sense about Science, the EU has decided to delay the introduction of the laws for 4 years while they are revised.

Comments

Avatar of: Stephen Keevil

Stephen Keevil

Posts: 1

October 23, 2007

As one of the scientists most closely involved in this campaign over the last few years, I'm glad that The Scientist has picked up this important story. However, there is one crucial point that needs to be clarified. The European Commission has not dropped the proposed new Directive, but has simply agreed to delay implementation by four years. This will allow them time to assess the scientific basis of the limits and of the claims that we in the MRI community are making. There is no guarantee that the same limits will not be presented again in a few years time - our campaign, I am afraid, is far from over!

Popular Now

  1. 2017 Top 10 Innovations
    Features 2017 Top 10 Innovations

    From single-cell analysis to whole-genome sequencing, this year’s best new products shine on many levels.

  2. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  3. Antiviral Immunotherapy Comes of Age
    News Analysis Antiviral Immunotherapy Comes of Age

    T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 

  4. Search for Life on the Red Planet
FreeShip